183 related articles for article (PubMed ID: 23853445)
1. Suprabasal expression of Ki-67 as a marker for the severity of oral epithelial dysplasia and oral squamous cell carcinoma.
Dwivedi N; Chandra S; Kashyap B; Raj V; Agarwal A
Contemp Clin Dent; 2013 Jan; 4(1):7-12. PubMed ID: 23853445
[TBL] [Abstract][Full Text] [Related]
2. Ki-67 Prognostic Value in Different Histological Grades of Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma.
Takkem A; Barakat C; Zakaraia S; Zaid K; Najmeh J; Ayoub M; Seirawan MY
Asian Pac J Cancer Prev; 2018 Nov; 19(11):3279-3286. PubMed ID: 30486632
[TBL] [Abstract][Full Text] [Related]
3. Expression of Ki-67 in normal oral epithelium, leukoplakic oral epithelium and oral squamous cell carcinoma.
Birajdar SS; Radhika M; Paremala K; Sudhakara M; Soumya M; Gadivan M
J Oral Maxillofac Pathol; 2014 May; 18(2):169-76. PubMed ID: 25328294
[TBL] [Abstract][Full Text] [Related]
4. Ki-67 Expression as a Prognostic Marker: A Comparative Immunohistochemical Analysis of Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma.
Gupta V; Ramalingam K; Yasothkumar D; Debnath D; Sundar V
Cureus; 2023 May; 15(5):e38941. PubMed ID: 37313057
[TBL] [Abstract][Full Text] [Related]
5. An Immunohistochemical Study Showing Ki-67 as an Analytical Marker in Oral Malignant and Premalignant Lesions.
Dash KC; Mahapatra N; Bhuyan L; Panda A; Behura SS; Mishra P
J Pharm Bioallied Sci; 2020 Aug; 12(Suppl 1):S274-S278. PubMed ID: 33149470
[TBL] [Abstract][Full Text] [Related]
6. Markers for dysplasia of the upper aerodigestive tract. Suprabasal expression of PCNA, p53, and CK19 in alcohol-fixed, embedded tissue.
Coltrera MD; Zarbo RJ; Sakr WA; Gown AM
Am J Pathol; 1992 Oct; 141(4):817-25. PubMed ID: 1384338
[TBL] [Abstract][Full Text] [Related]
7. Expression of p63 in potentially malignant and malignant oral lesions.
Sinha A; Chandra S; Raj V; Zaidi I; Saxena S; Dwivedi R
J Oral Biol Craniofac Res; 2015; 5(3):165-72. PubMed ID: 26605141
[TBL] [Abstract][Full Text] [Related]
8. Suprabasal expression of Ki-67 antigen as a marker for the presence and severity of oral epithelial dysplasia.
Gonzalez-Moles MA; Ruiz-Avila I; Rodriguez-Archilla A; Martinez-Lara I
Head Neck; 2000 Oct; 22(7):658-61. PubMed ID: 11002319
[TBL] [Abstract][Full Text] [Related]
9. Expression of human telomerase reverse transcriptase protein in oral epithelial dysplasia and oral squamous cell carcinoma: An immunohistochemical study.
Raghunandan BN; Sanjai K; Kumaraswamy J; Papaiah L; Pandey B; Jyothi BM
J Oral Maxillofac Pathol; 2016; 20(1):96-101. PubMed ID: 27194869
[TBL] [Abstract][Full Text] [Related]
10. E-cadherin Expression in Premalignant Lesions, Premalignant Conditions, Oral Squamous Cell Carcinoma, and Normal Mucosa: An Immunohistochemical Study.
Kalaimani G; Rao UDK; Joshua E; Ranganathan K
Cureus; 2023 Aug; 15(8):e44266. PubMed ID: 37772225
[TBL] [Abstract][Full Text] [Related]
11. Comparative evaluation of immunohistochemical expression of MCM2 and Ki67 in oral epithelial dysplasia and oral squamous cell carcinoma.
Swain S; Nishat R; Ramachandran S; Raghuvanshi M; Behura SS; Kumar H
J Cancer Res Ther; 2022; 18(4):997-1002. PubMed ID: 36149152
[TBL] [Abstract][Full Text] [Related]
12. Immunohistological evaluation of Ki-67, p63, CK19 and p53 expression in oral epithelial dysplasias.
Takeda T; Sugihara K; Hirayama Y; Hirano M; Tanuma JI; Semba I
J Oral Pathol Med; 2006 Jul; 35(6):369-75. PubMed ID: 16762018
[TBL] [Abstract][Full Text] [Related]
13. PITX1 is a reliable biomarker for predicting prognosis in patients with oral epithelial dysplasia.
Nakabayashi M; Osaki M; Kodani I; Okada F; Ryoke K; Oshimura M; Ito H; Kugoh H
Oncol Lett; 2014 Mar; 7(3):750-754. PubMed ID: 24527083
[TBL] [Abstract][Full Text] [Related]
14. A comparative analysis of langerhans cell in oral epithelial dysplasia and oral squamous cell carcinoma using antibody CD-1a.
Upadhyay J; Rao NN; Upadhyay RB
J Cancer Res Ther; 2012; 8(4):591-7. PubMed ID: 23361280
[TBL] [Abstract][Full Text] [Related]
15. Immunoexpression of programmed cell death 4 protein in normal oral mucosa, oral epithelial dysplasia and oral squamous cell carcinoma.
Desai KM; Kale AD
J Oral Maxillofac Pathol; 2017; 21(3):462. PubMed ID: 29391736
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical evaluation of myofibroblasts in oral epithelial dysplasia and oral squamous cell carcinoma.
Pinisetti S; Tadi D; Manyam R; Alla R
J Oral Maxillofac Pathol; 2021; 25(3):494-498. PubMed ID: 35281169
[TBL] [Abstract][Full Text] [Related]
17. An immunohistochemical study of basement membrane heparan sulfate proteoglycan (perlecan) in oral epithelial dysplasia and squamous cell carcinoma.
Mishra M; Chandavarkar V; Naik VV; Kale AD
J Oral Maxillofac Pathol; 2013 Jan; 17(1):31-5. PubMed ID: 23798826
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical study of syndecan-1 down-regulation and the expression of p53 protein or Ki-67 antigen in oral leukoplakia with or without epithelial dysplasia.
Kurokawa H; Matsumoto S; Murata T; Yamashita Y; Tomoyose T; Zhang M; Fukuyama H; Takahashi T
J Oral Pathol Med; 2003 Oct; 32(9):513-21. PubMed ID: 12969225
[TBL] [Abstract][Full Text] [Related]
19. Ki-67 is an independent prognostic marker for the recurrence and relapse of oral squamous cell carcinoma.
Jing Y; Zhou Q; Zhu H; Zhang Y; Song Y; Zhang X; Huang X; Yang Y; Ni Y; Hu Q
Oncol Lett; 2019 Jan; 17(1):974-980. PubMed ID: 30655856
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical location of the p75 neurotrophin receptor (p75NTR) in oral leukoplakia and oral squamous cell carcinoma.
Kiyosue T; Kawano S; Matsubara R; Goto Y; Hirano M; Jinno T; Toyoshima T; Kitamura R; Oobu K; Nakamura S
Int J Clin Oncol; 2013 Feb; 18(1):154-63. PubMed ID: 22170235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
